$ISRG

Intuitive Surgical (ISRG) Q3 Earnings Beat Expectations with Str

Intuitive Surgical (ISRG) reported Q3 earnings that surpassed expectations, with revenue of $3.05B, up 21.5% YoY, and EPS of $3.00. The company saw a 15% rise in procedures and placed 546 new da Vinci systems. ISRG's GF Value suggests it is undervalued by 31.1%, with a GF Score of 96/100. Insiders sold $93.4M in shares, while gurus show mixed activity.

Original reporting
Published Oct 20, 2026, 8:58 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 20, 2026, 10:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$ISRG
Bullish
high confidence
Mentioned
$ISRG
Relevance
8/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ISRGBullishMed
01

Why it matters

The earnings beat is likely to trigger buying interest, though insider sales and a high valuation may temper enthusiasm.

02

Market read

Strong earnings from a large-cap healthcare device maker can lift the sector and attract short-term trader interest.

03

What to watch

High valuation multiples (P/E 50.2x) and moderate momentum may limit upside in the near term.

Relevance 8/10Novelty 8/10Timing: after-hours reaction

Background

Intuitive Surgical reported Q3 2026 results, beating consensus estimates on both EPS and revenue, and highlighted growth in da Vinci and Ion procedure volumes.

Company-level read

Ticker impact

$ISRGBullishHigh confidence
Context

Q3 earnings beat expectations with $3.00 EPS and $3.05B revenue, plus strong procedure volume growth.

Expected impact

likely upward pressure as investors price in the earnings beat and strong growth metrics

Evidence & confidence

The company delivered better-than-expected earnings and revenue, and highlighted procedural volume increases, which typically drive short-term buying.

Market effects

Strengthens the medical devices sector outlook as a leading robotic surgery player shows robust growth.

Positive for U.S. healthcare equities, especially other surgical robotics firms.

Reinforces confidence in global demand for minimally invasive surgical technology.

Counterpoint

Insider selling of $93.4M could signal management concerns despite the earnings beat.

Key entities

  • Intuitive Surgical Inc.

    Leader in robotic-assisted minimally invasive surgery.

Related articles

$ISRGMedAI 8/10

Intuitive Surgical, Inc (ISRG) Q3 2026 Earnings Call Transcript

Intuitive Surgical (ISRG) reported Q3 2026 earnings, highlighting 15% total procedure growth, with 14% in da Vinci and 31% in Ion procedures. U.S. da Vinci growth was 10%, while international growth was 20%. The company installed over 13,200 da Vinci and Ion systems worldwide. Revenue growth was driven by strong demand for da Vinci 5 and SP platforms, with 28% increase in system placements. The company also announced plans for a new manufacturing facility in Malaysia.

$ISRGHighAI 8/10

Stocks making the biggest moves after hours: Super Micro Computer, Intuitive Surgical, Netflix, SpaceX & more

Intuitive Surgical (ISRG) fell 10% after Q3 results missed expectations, while SpaceX shares rose 2% on a 161% revenue jump. Netflix (NFLX) dropped 5% despite in-line sales. Capital One (COF) gained 5% on higher net income. United Airlines (UAL) declined 2% after earnings trailed estimates. Super Micro Computer (SMCI) surged 12% on an upgraded revenue outlook.